PPB Warns Against Counterfeit Cancer Drugs
Global Alert Issued
The Pharmacy and Poisons Board (PPB) has warned Kenyans about counterfeit cancer drugs circulating globally. Moreover, the falsified medicines contain no active ingredients and pose serious risks to patients.
Fake IBRANCE Identified
PPB confirmed fake versions of IBRANCE, a breast cancer drug, are in circulation. Additionally, nine dangerous batches have been flagged in Lebanon, Ivory Coast, Turkiye, Egypt, and Libya.
Laboratory Tests Confirm Risks
Tests revealed the counterfeit drugs contain zero active ingredients. Consequently, they are useless for cancer treatment and endanger patient health.
Fraudulent Packaging Features
The fake products claim to be made by Pfizer but are poorly manufactured. Labels show spelling mistakes, poor printing, and unusual security seals with black ink logos.
Capsule Irregularities
The capsules are marked incorrectly and display strange colors like bright orange. Therefore, they can be easily distinguished from genuine products.
PPB Urges Reporting
PPB urged hospitals, pharmacies, and citizens to report suspicious batches immediately. Reports can be made via USSD code *271# or phone number 0795743049.
Kenya’s Preventive Measures
So far, no counterfeit batches have been found in Kenya. However, PPB stressed the warning is preventive and aims to protect citizens.
Public Safety Reminder
The board emphasized that buying medicine from unlicensed sellers is illegal. Furthermore, it continues monitoring all health products entering Kenya to safeguard public health.
Counterfeit cancer drugs pose global risks. Ultimately, PPB’s alert reinforces vigilance and commitment to protecting Kenyan patients from dangerous medicines.
